
rapaflo
Pharmaranks rates Rapaflo 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Rapaflo (Silodosin) is an alpha-adrenergic blocker used to treat Prostatic Hyperplasia.
Silodosin · by Abbvie
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Silodosin
- Drug class
- Alpha-Adrenergic Blocker
- Form
- Capsule
- Strength
- Silodosin 4MG · Silodosin 8MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- prostatic hyperplasia
- Manufacturer
- Abbvie
- What the pharmacy pays
- ~$9.29 for 30 — not your price
- FDA application
- NDA022206
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Alpha-Blockers - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Rapaflo ranks — best-rated alpha-adrenergic blocker for:
Dosage forms
Capsule
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Rapaflo treat?
- Rapaflo (Silodosin) may be used to treat prostatic hyperplasia, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Rapaflo work?
- Rapaflo is a alpha-adrenergic blocker. Alpha-adrenergic blockers block the alpha-1 receptors that adrenaline-like signals use to tighten muscle in blood vessels and the prostate. This relaxes those muscles, lowering blood pressure and easing urine flow in men with an enlarged prostate.
- How is Rapaflo rated?
- pharmaranks gives Rapaflo a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Rapaflo cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $9.29 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Coreg — about $0.63 on the same basis.
- Is there a coupon or discount for Rapaflo?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Rapaflo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Rapaflo?
- Rapaflo is marketed by Abbvie. You can see Abbvie's full profile, rating, and other products on pharmaranks.
- Is Rapaflo a brand-name or generic drug?
- Rapaflo is a brand-name product with the active ingredient Silodosin.
- Is Rapaflo available over the counter?
- No. Rapaflo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Rapaflo come in?
- Rapaflo is currently marketed as capsule, per the FDA's National Drug Code Directory.
- What class of drug is Rapaflo?
- Rapaflo is classified as alpha-adrenergic blocker, per the FDA's Established Pharmacologic Class.
- Is Rapaflo FDA-registered?
- Rapaflo is on record with the U.S. FDA under application number NDA022206. You can verify this on its official FDA label.
- Has Rapaflo been recalled by the FDA?
- Rapaflo has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Rapaflo safe?
- There's no single safe-or-not verdict. pharmaranks gives Rapaflo a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cardura
Doxazosin Mesylate
tamsulosin hydrochloride
Tamsulosin Hydrochloride
cardura xl
Doxazosin Mesylate
minipress
Prazosin Hydrochloride
coreg
Carvedilol
coreg cr
Carvedilol Phosphate
Compare Rapaflo head-to-head
More alpha-adrenergic blocker drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
rapaflo
72/100